Listed on GrantGunner. Last checked 15 Nov 2026.
About this grant
Call for applications for a specialized accelerator program designed for high-potential companies operating at the intersection of health technology, technology biotechnology, and pharmaceutical research and development. This three-month hybrid program is specifically designed to help early-stage founders refine their value propositions and establish key partnerships within the global pharmaceutical industry. The accelerator provides a tuition-free curriculum, mentorship, access to the Basel life sciences network, and the opportunity to secure up to 50,000 Swiss francs in funding.